Hla –dq Locus Typing

What is HLA-DQ Locus Typing test?

An HLA-DQ locus typing test analyzes specific genes within the Human Leukocyte Antigen (HLA) complex to determine the presence of genetic predispositions for certain autoimmune conditions, particularly celiac disease. By detecting specific HLA-DQ alleles like HLA-DQ2 and HLA-DQ8, which are strongly associated with celiac disease, the test can help assess a person's risk and aid in diagnosing the disorder.

Why consider HLA-DQ Locus Typing test?

• Transplant compatibility: HLA‑DQ mismatches and donor‑specific anti‑DQ antibodies are important drivers of antibody‑mediated rejection and chronic allograft injury; precise DQ typing supports donor selection and risk‑tailored immunosuppression.
• Antibody mapping: Exact DQA1/DQB1 alleles help interpret class II donor‑specific antibodies on solid‑phase assays and anticipate crossmatch outcomes, reducing unexpected incompatibilities.
• Comprehensive profiling: Including DQ with DR (and often DP) completes class II assessment, aligning with contemporary transplant protocols and registry practices that emphasize multi‑locus typing at higher resolution.

Who should get tested for HLA-DQ Locus Typing test?

• Transplant candidates and donors: Individuals evaluated for kidney, liver, heart, lung, or HSCT where multi‑locus class I and II HLA data guide allocation and compatibility decisions.
• Sensitized recipients: Patients with class II antibodies who require precise DQ allele data for virtual crossmatch and desensitization planning before donor offers.
• Donor registries/cord units: Programs that type DQ with DR (±DP) at confirmatory or high resolution to optimize unrelated donor selection and reduce immunogenic mismatches.

More Information about HLA-DQ Locus Typing test

HLA is central to transplant compatibility: matching donor and recipient HLA types and ensuring no donor‑specific HLA antibodies are present reduces rejection risk, improves graft survival, and guides immunosuppression strategies. A mismatch between a donor's and recipient's HLAs can trigger an immune response, leading to graft (transplanted organ or tissue) rejection. HLA matching aims to find a donor whose HLAs are as similar as possible to the recipient's, which increases the likelihood of graft acceptance and reduces the risk of rejection and other complications.

OTHER NAMES: HLA‑DQ typing / HLA‑DQA1 and ‑DQB1 allele typing, High‑resolution HLA‑DQ genotyping, HLA class II (DQ locus) DNA typing.